
Beijing LabTech Instruments Co., Ltd.
LabTech
Beijing LabTech Instruments Co., Ltd., which sells under the LabTech brand, is a Chinese manufacturer of laboratory analytical instruments and sample-preparation equipment based in the Tianzhu Airport Industrial Zone in Beijing's Shunyi District. It was founded in 2002 and listed on the Shanghai Stock Exchange STAR Market on 2 September 2020 at RMB 24.80 per share under ticker 688056. The business is analytical instrumentation, not education hardware: it builds instruments that digest, extract, purify, separate and measure samples for environmental monitoring, food and agricultural testing, pharmaceutical quality control and semiconductor analysis.
Total operating revenue for the 2025 financial year was RMB 401.08 million, down 5.41 percent year on year, while net profit attributable to shareholders rose 3.19 percent to RMB 40.40 million and non-recurring-adjusted net profit rose 10.25 percent to RMB 34.14 million. R&D spending reached RMB 48.54 million, 12.10 percent of revenue. Overseas sales grew 22.17 percent to RMB 78.54 million, 19.72 percent of main-business revenue. In the first half of 2026 revenue was RMB 189.90 million, down 1.07 percent, with net profit attributable to shareholders down 36.60 percent to RMB 13.37 million even though second-quarter revenue rose 11.01 percent.
The product range is broad and instrument-led. LabTech's flagship analytical line is its inductively coupled plasma mass spectrometry family, the LabMS 3000, LabMS 3300 and triple-quadrupole LabMS 5000 ICP-MS/MS, joined by ICP-OES, atomic absorption and atomic fluorescence spectrometers. Around those sit a deep sample-preparation portfolio: the REVO microwave digestion line, graphite digestion, automated solid-phase extraction, accelerated solvent and pressure extraction, GPC1000 gel permeation clean-up, automated concentration, the PT3000 purge-and-trap and PY1000 pyrolysis instruments, and consumables sold under the CDS and Empore names.
VerityRank places LabTech in the Top 10 Educational Laboratory Instruments Brands because universities and research institutes are a real, growing and disclosed customer group. The company's 2025 annual report states that research institutes and universities and colleges generated RMB 37.96 million, or 9.53 percent of main-business revenue and 9.46 percent of total revenue, up 35.35 percent year on year. That is far smaller than the education specialists on this page, and LabTech is not an education-first company. The frequently cited claim that teaching and research laboratories account for about 35 percent of turnover is a misreading of the segment's 35.35 percent growth rate.
Manufacturing is genuinely in-house, with production in Beijing and Tianjin supplemented by LabTech, Inc. in Hopkinton, Massachusetts and CDS Analytical, LLC in Oxford, Pennsylvania, whose pyrolysis and thermal desorption instruments descend from equipment used for ground-reference work on NASA's Mars Curiosity sample-analysis module. The group owns the LabTech, CDS and Empore brands and held 162 granted patents and 83 software copyrights at the end of 2025.
LabTech's principal risks are profitability under investment and a share price detached from its fundamentals. Research intensity is climbing faster than revenue, and the company has twice published severe-abnormality notices after sharp rises driven by semiconductor-themed speculation, in June and September 2026, noting that semiconductor-related revenue remains under 2 percent of turnover and that all ICP-MS sales were only 8.03 percent of revenue in 2025.Read MoreShow Less
Listed market data
688056 · SSE · weeklyHistory →- Share price
- CNY 33.48
- 1Y change
- +6.4%
- Recent change
- -11.6%
- Since first close
- -29.4%
- Revenue (TTM)
- RMB$401 M (FY2025, down 5.41%); net profit RMB$40.4 M, up 3.19%
11-13 → 11-16
from 2020
Financial history
Full market history- 2026-11CNY 33.48—-13.3%
- 2026-10CNY 38.60—-22.6%
- 2026-09CNY 49.90—+15.2%
- 2026-08CNY 43.33—+25.9%
- 2026-07CNY 34.41—-46.7%
- 2026-06CNY 64.55—+101.8%
- 2026-05CNY 31.99—-12.9%
- 2026-04CNY 36.73—+7.5%
- 2026-03CNY 34.16—-13.9%
- 2026-02CNY 39.68—+8.1%
- 2026-01CNY 36.71—+9.2%
- 2025-12CNY 33.61——
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Brand & Manufacturer
- Insiders
- 67.46%
- Institutions
- 1.92%(24 holders)
- Free float
- 5.88%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
• REVO microwave digestion and graphite digestion systems
• Automated solid-phase extraction SPE1000PLUS, AutoEmpore and Empore membranes
• Accelerated solvent and pressure extraction FlexHPSE and GPC1000 gel permeation clean-up
Elemental & Molecular Analysis – the high-value growth line
• LabMS 5000 triple-quadrupole ICP-MS/MS, plus LabMS 3000 and LabMS 3300 ICP-MS
• LabICP 1000 and LabICP 2000 ICP-OES, LabAA 2000 atomic absorption
• EvoLab intelligent full-process elemental analysis system
Thermal Analysis & Consumables – made by CDS Analytical in the United States
• PT3000 purge-and-trap and PY1000 and CDS 6200 pyrolysis and thermal desorption
• CDS and Empore consumables, plus the EmporeOmics automation platform
Clean Laboratory Solutions – engineering and fit-out business
• Clean and ultra-clean chemistry laboratories
• Laboratory ventilation, gas supply and pure water systems
Quick Facts
Headquarters
Founded
Employees
Revenue
Factories
Presence
Listing
Categories
Related
Similar listed companies
- Thermo Fisher Scientific Inc.· $257 B
- The Linde Group· $247 B
- Siemens AG· $235 B
- Abbott Laboratories· $199 B
- KLA· $180 B
- Tokyo Electron· $175 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website SSE STAR Market: 688056 (listed September 2020) , LabTech Official Site · FY2025 Annual Report (SSE Filing) · H1 2026 Report Summary · SSE Company Profile 688056 · Tianjin Manufacturing Base · CDS Analytical (LabTech USA)
